These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27477214

  • 1. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group.
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [Abstract] [Full Text] [Related]

  • 2. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D study group.
    Antivir Ther; 2017 Apr; 22(6):471-479. PubMed ID: 27786155
    [Abstract] [Full Text] [Related]

  • 3. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D Study Group.
    AIDS; 2016 Apr 24; 30(7):1059-67. PubMed ID: 26807972
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 5. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
    Rukuni R, Rehman AM, Mukwasi-Kahari C, Madanhire T, Kowo-Nyakoko F, McHugh G, Filteau S, Chipanga J, Simms V, Mujuru H, Ward KA, Ferrand RA, Gregson CL.
    Lancet Child Adolesc Health; 2021 Aug 01; 5(8):569-581. PubMed ID: 34139202
    [Abstract] [Full Text] [Related]

  • 6. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W, Chin D, Silverberg AI, Lashiker L, Khateeb N, Anhalt H.
    Pediatrics; 2001 May 01; 107(5):E79. PubMed ID: 11331729
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in children and adolescents with perinatal HIV infection.
    DiMeglio LA, Wang J, Siberry GK, Miller TL, Geffner ME, Hazra R, Borkowsky W, Chen JS, Dooley L, Patel K, van Dyke RB, Fielding RA, Gurmu Y, Jacobson DL, Pediatric HIVAIDS Cohort Study (PHACS).
    AIDS; 2013 Jan 14; 27(2):211-20. PubMed ID: 23032412
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec 14; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 9. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
    Gregson CL, Hartley A, Majonga E, McHugh G, Crabtree N, Rukuni R, Bandason T, Mukwasi-Kahari C, Ward KA, Mujuru H, Ferrand RA.
    Bone; 2019 Aug 14; 125():96-102. PubMed ID: 31082498
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J, Viget N, Drumez E, Cortet B, Robineau O.
    Med Mal Infect; 2018 Oct 14; 48(7):442-448. PubMed ID: 29699830
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E, Szubert A, Otike C, Namyalo I, Nambi E, Bamford A, Doerholt K, Gibb DM, Musiime V, Musoke P.
    PLoS One; 2023 Oct 14; 18(7):e0288877. PubMed ID: 37471330
    [Abstract] [Full Text] [Related]

  • 12. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.
    AIDS; 2018 Nov 28; 32(18):2689-2696. PubMed ID: 30234605
    [Abstract] [Full Text] [Related]

  • 13. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Kwak MK, Lee EJ, Park JW, Park SY, Kim B-, Kim TH, Suh K, Koh J-, Lee SH, Byun D-.
    Osteoporos Int; 2019 Jul 28; 30(7):1501-1510. PubMed ID: 30915506
    [Abstract] [Full Text] [Related]

  • 14. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L, Katlama C, Viard JP, Bentata M, Simon A, Roux C, Kolta S, Costagliola D, Rozenberg S, ANRS Osteovir study group.
    AIDS; 2013 Sep 24; 27(15):2425-30. PubMed ID: 24029735
    [Abstract] [Full Text] [Related]

  • 15. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.
    Jiménez B, Sainz T, Díaz L, Mellado MJ, Navarro ML, Rojo P, González-Tomé MI, Prieto L, Martínez J, de José MI, Ramos JT, Muñoz-Fernandez MÁ, Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Pediatric Branch of the Spanish National AIDS Research Network (CoRISpe).
    Pediatr Infect Dis J; 2017 Jun 24; 36(6):578-583. PubMed ID: 28005690
    [Abstract] [Full Text] [Related]

  • 16. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG, Sabin CA, Simelane S, Macken A, Kavanagh E, Brady JJ, McCarthy G, Compston J, Mallon PW, HIV UPBEAT Study Group.
    AIDS; 2014 Sep 10; 28(14):2051-60. PubMed ID: 25265073
    [Abstract] [Full Text] [Related]

  • 17. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC, Klink DT, den Heijer M, Blankenstein MA, Rotteveel J, Heijboer AC.
    Bone; 2017 Feb 10; 95():11-19. PubMed ID: 27845262
    [Abstract] [Full Text] [Related]

  • 18. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.
    Pitukcheewanont P, Safani D, Church J, Gilsanz V.
    Osteoporos Int; 2005 Nov 10; 16(11):1393-6. PubMed ID: 15702261
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 10; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 20. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
    Rukuni R, Gregson C, Kahari C, Kowo F, McHugh G, Munyati S, Mujuru H, Ward K, Filteau S, Rehman AM, Ferrand R.
    BMJ Open; 2020 Feb 09; 10(2):e031792. PubMed ID: 32041852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.